Categories
Calendar
| M | T | W | T | F | S | S |
|---|---|---|---|---|---|---|
| « Jan | Mar » | |||||
| 1 | 2 | 3 | 4 | 5 | ||
| 6 | 7 | 8 | 9 | 10 | 11 | 12 |
| 13 | 14 | 15 | 16 | 17 | 18 | 19 |
| 20 | 21 | 22 | 23 | 24 | 25 | 26 |
| 27 | 28 | 29 | ||||
Tags
- Almus
- Alphega Pharmacy
- arrangements
- Charity
- Class 1 Drug Alert
- Class 2 Drug Alert
- Class 3 Drug Alert
- Class 4 Drug Alert
- Clic Sargent
- Corporate Social Responsibility
- CSR
- Data Protection Act
- Department of Health
- Discount
- Dispensing Doctor
- Distribution agreement
- Drug Alert (Wholesaler Recall)
- Drug Alert: (Caution in use)
- Event
- Finance
- Fuel surcharge
- Golf week
- GPhC
- Hospital Pharmacy
- Independent Pharmacy
- Information Governance Toolkit
- Leonard Cheshire
- licence
- Lundbeck
- Medical Device Alert
- medical spend
- Medical Terms
- NAPP
- Pharmacy Awards
- Professional Services
- Prostate Cancer
- Reckitt Benckiser
- Retro statements
- Seasonal flu
- supply
- Tamiflu
- terms and conditions
- The Dispenser
- Voluntary Drug Alert
- webprescriptions
Archives : 2012/2/17
-
Friday 17 February 2012
Class 4 Drug Alert (Caution in use): Clexane S PFS Inj 40mg X10(S/Lock)
Sanofi-aventis have informed us that the needle caps on some syringes of the below batch require more force than usual for removal. The affected syringes can still be used but users are advised to be vigilant when preparing syringes from this batch for use. The quality of the contents of the syringes is not compromised by this finding.